GLP-1 Receptor Agonist Bioanalysis: Quantifying Semaglutide and Tirzepatide in Plasma by LC-MS/MS
Introduction: GLP-1 receptor agonist bioanalysis is the validated measurement of drugs such as semaglutide and tirzepatide in plasma, and liquid […]
Introduction: GLP-1 receptor agonist bioanalysis is the validated measurement of drugs such as semaglutide and tirzepatide in plasma, and liquid […]
Introduction Partnering with a qualified Biosimilar CDMO in Canada allows biotechnology sponsors to obtain the comparative analytical characterization, formulation stability
Introduction Selecting a Biosimilar CDMO in the United States requires a thorough assessment of its FDA site inspection history, orthogonal
Biosimilar CDMO in the United States: How to Choose a Specialized Development Partner Read More »
Introduction Designing a regulatory-ready bioequivalence (BE) study for Generic Orforglipron Development requires careful consideration of several critical factors, including an
Introduction: Drug Product Nitrosamine Testing is the analysis of the finished dosage form (tablet, capsule, injection, inhaler, patch or other)
Introduction Generic Semaglutide Development in 2026 is characterized by a divided global regulatory landscape. Canada and several early-opening emerging markets
Generic semaglutide (Ozempic/Wegovy) for Canada and emerging markets, ANDA route Read More »
Introduction What is a Biologics Contract Development and Manufacturing Organization (CDMO) in practical biopharmaceutical operations? A biologics CDMO serves as
Introduction: Sponsors and manufacturers often ask us the same question once a risk assessment flags a possible nitrosamine concern: how
How Many Batches Need Nitrosamine Confirmatory Testing? Sampling Strategy Explained Read More »
Introduction cGMP Peptide Manufacturing Services Canada provide comprehensive support across chemical synthesis, preparative chromatographic purification, counter-ion exchange, controlled lyophilization, orthogonal
What Does a cGMP Peptide CDMO in Canada Actually Offer? Read More »
Introduction Biopharmaceutical sponsors confronting geopolitical supply restrictions, significant global capacity constraints, and evolving cross-border trade regulations are increasingly choosing to
Why Source Your Peptides from a Canadian CDMO? (Supply Chain & Reshoring) Read More »